0001209191-23-005746.txt : 20230131 0001209191-23-005746.hdr.sgml : 20230131 20230131171439 ACCESSION NUMBER: 0001209191-23-005746 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230127 FILED AS OF DATE: 20230131 DATE AS OF CHANGE: 20230131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOYLE THOMAS JAMES CENTRAL INDEX KEY: 0001910331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 23573402 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-27 0 0001422143 Kura Oncology, Inc. KURA 0001910331 DOYLE THOMAS JAMES C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 SVP, Finance & Accounting Common Stock 2023-01-27 4 S 0 682 13.8898 D 17707 D Common Stock 2023-01-27 4 S 0 866 13.8902 D 16841 D Common Stock 500 I spouse's 401(k) Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 1/26/22. Includes 1,806 shares acquired on May 17, 2022 and 1,583 shares acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan. Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 2/7/22. Teresa Bair, Attorney-in-fact for Thomas Doyle 2023-01-31